journal article·2023-12-31Open access

Generation of a novel ex-vivo model to study re-endothelialization

Siti Sarah Azman, Muhammad Dain Yazid, Nur Azurah Abdul Ghani, Raja Zahratul Azma Raja Sabudin, Mohd Ramzisham Abdul Rahman, Nadiah Sulaiman

Abstract

Endothelial dysfunction initiates the pathogenesis of a myriad of cardiovascular diseases, yet the precise underlying mechanisms remain unclear. Current model utilises mechanical denudation of arteries resulting in an arterial-injury model with onset of intimal hyperplasia (IH). Our study shows that 5 min enzymatic denudation of human umbilical artery (hUA) lumen at 37 °C efficiently denudes hUA while maintaining vessel integrity without significantly increase intima-media thickness after 7 days in culture. This ex-vivo model will be a valuable tool in understanding the mechanism of re-endothelialization prior to smooth muscle cells (SMC) activation thus placating IH at an early stage.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Angiogenesis and VEGF in Cancer · Nitric Oxide and Endothelin Effects · Coronary Interventions and Diagnostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Centre for Tissue Engineering and Regenerative Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Malaysia

Faculty of Applied Sciences, Universiti Teknologi MARA, Perak Branch, Tapah Campus, Perak, Malaysia

Department of Obstetrics and Gynaecology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Malaysia

Hospital Canselor Tuanku Mukhriz, Jalan Yaacob Latif, Bandar Tun Razak, Cheras, Kuala Lumpur, Malaysia

Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Malaysia

Department of Surgery, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Malaysia

Funding

Universiti Kebangsaan Malaysia

References (35)

Show source-provided references
1. 10.3390/ijms2018441110.3390/ijms20184411 ↗
2. 10.1016/j.cardiores.2004.04.02810.1016/j.cardiores.2004.04.028 ↗
3. 10.1007/s10741-019-09881-310.1007/s10741-019-09881-3 ↗
4. 10.1111/j.1538-7836.2011.04218.x10.1111/j.1538-7836.2011.04218.x ↗
5. 10.1152/ajpheart.00325.201110.1152/ajpheart.00325.2011 ↗
6. 10.5339/gcsp.2014.4310.5339/gcsp.2014.43 ↗
7. 10.1097/00005344-198900146-0000510.1097/00005344-198900146-00005 ↗
8. 10.1016/j.yjmcc.2015.11.01310.1016/j.yjmcc.2015.11.013 ↗
9. 10.3389/fphar.2019.0156810.3389/fphar.2019.01568 ↗
10. 10.1080/21691401.2017.133703010.1080/21691401.2017.1337030 ↗
11. 10.3389/fmed.2021.79895810.3389/fmed.2021.798958 ↗
12. 10.4330/wjc.v7.i11.71910.4330/wjc.v7.i11.719 ↗
13. 10.1080/08923973.2022.209374010.1080/08923973.2022.2093740 ↗
14. 10.1016/j.thromres.2018.07.01410.1016/j.thromres.2018.07.014 ↗
15. 10.1007/978-1-59745-571-8_110.1007/978-1-59745-571-8_1 ↗
16. 10.1016/j.bcp.2022.11494710.1016/j.bcp.2022.114947 ↗
17. 10.1016/j.atherosclerosis.2017.08.02310.1016/j.atherosclerosis.2017.08.023 ↗
18. 10.1177/096368971879220110.1177/0963689718792201 ↗
19. 10.1111/j.1748-1716.1993.tb09545.x10.1111/j.1748-1716.1993.tb09545.x ↗
20. 10.1159/00015878110.1159/000158781 ↗
21. 10.3109/1062332960902470410.3109/10623329609024704 ↗
22. 10.1016/j.jmbbm.2019.10355010.1016/j.jmbbm.2019.103550 ↗
23. 10.1038/s41551-021-00777-y10.1038/s41551-021-00777-y ↗
24. 10.3389/fcvm.2022.86675110.3389/fcvm.2022.866751 ↗
25. 10.3390/ph1003007010.3390/ph10030070 ↗
26. 10.1073/pnas.033486410010.1073/pnas.0334864100 ↗
27. 10.1038/s41598-020-68870-x10.1038/s41598-020-68870-x ↗
28. 10.1007/s00441-008-0706-510.1007/s00441-008-0706-5 ↗
29. 10.1016/j.isci.2021.10267510.1016/j.isci.2021.102675 ↗
30. 10.1016/j.yexmp.2017.02.00510.1016/j.yexmp.2017.02.005 ↗
31. 10.3390/cancers1312287010.3390/cancers13122870 ↗
32. 10.18632/oncotarget.2236510.18632/oncotarget.22365 ↗
33. 10.1038/s41467-020-15361-210.1038/s41467-020-15361-2 ↗
34. 10.1007/s12257-022-0256-910.1007/s12257-022-0256-9 ↗
35. 10.1089/ten.tea.2008.052610.1089/ten.tea.2008.0526 ↗